Guilford Street Laboratories raises £1.9m for AI-driven biomarker diagnostics
Precision diagnostics developer Guilford Street Laboratories has raised an estimated £1.9m to expand its AI-driven biomarker assay platform. This latest funding round values the Liverpool-based compan...